Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022
Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report “Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) – World Forecasts to 2022” studies the market for the application of microfluidics in pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.
On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.
According to analysis, the market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.
Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.
Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.
In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.
The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.
On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.
According to analysis, the market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.
Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.
Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.
In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.
The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. MICROFLUIDICS - AN INTRODUCTION
4. MICROFLUIDICS MARKET OVERVIEW
4.1 Microfluidics Market
4.2 Healthcare Microfluidics Market
5. DRIVERS & CHALLENGES
5.1 Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Increasing Demand of Point of Care Diagnostics
5.1.3 Rising Application in Life Sciences Research
5.1.4 Benefits of Miniaturization of Chip
5.2 Challenges
5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
5.2.2 Ambiguous Regulatory Framework
5.2.3 Lack of Awareness in Emerging Markets
6. MARKET SEGMENTATION
6.1 By Material
6.1.1 Ceramics
6.1.2 Polymers
6.1.3 Others
6.2 By Components
6.2.1 Microfluidics Chips Based Microfluidic Devices
6.2.2 Microfluidics Pumps Based Microfluidic Devices
6.2.3 Microfluidics Needles Based Microfluidic Devices
6.2.4 Others
6.3 By Applications
6.3.1 In–Vitro Diagnostics
6.3.2 Pharmaceutical & Life Sciences Research
6.3.3 Drug Delivery
6.3.4 Others
6.4 By Geography
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Rest of World
7. REGULATORY SCENARIO
7.1 US
7.2 Europe
7.3 Asia-Pacific
7.3.1 India
7.3.2 China
8. TRENDS & DEVELOPMENTS
8.1 Grants Announced for Microfluidics Research
8.2 Mergers & Acquisitions
9. COMPETITIVE ASSESSMENT
9.1 Fluidigm Corporation
9.2 F. Hoffmann-La Roche Ltd.
9.3 Bio-Rad Laboratories, Inc.
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 Perkin Elmer, Inc.
9.7 Illumina, Inc.
9.8 Shimadzu Corporation
9.9 Danaher Corporation
9.10 Abbott
2. RESEARCH METHODOLOGY
3. MICROFLUIDICS - AN INTRODUCTION
4. MICROFLUIDICS MARKET OVERVIEW
4.1 Microfluidics Market
4.2 Healthcare Microfluidics Market
5. DRIVERS & CHALLENGES
5.1 Drivers
5.1.1 Rising Incidence of Chronic Diseases
5.1.2 Increasing Demand of Point of Care Diagnostics
5.1.3 Rising Application in Life Sciences Research
5.1.4 Benefits of Miniaturization of Chip
5.2 Challenges
5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
5.2.2 Ambiguous Regulatory Framework
5.2.3 Lack of Awareness in Emerging Markets
6. MARKET SEGMENTATION
6.1 By Material
6.1.1 Ceramics
6.1.2 Polymers
6.1.3 Others
6.2 By Components
6.2.1 Microfluidics Chips Based Microfluidic Devices
6.2.2 Microfluidics Pumps Based Microfluidic Devices
6.2.3 Microfluidics Needles Based Microfluidic Devices
6.2.4 Others
6.3 By Applications
6.3.1 In–Vitro Diagnostics
6.3.2 Pharmaceutical & Life Sciences Research
6.3.3 Drug Delivery
6.3.4 Others
6.4 By Geography
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Rest of World
7. REGULATORY SCENARIO
7.1 US
7.2 Europe
7.3 Asia-Pacific
7.3.1 India
7.3.2 China
8. TRENDS & DEVELOPMENTS
8.1 Grants Announced for Microfluidics Research
8.2 Mergers & Acquisitions
9. COMPETITIVE ASSESSMENT
9.1 Fluidigm Corporation
9.2 F. Hoffmann-La Roche Ltd.
9.3 Bio-Rad Laboratories, Inc.
9.4 Thermo Fisher Scientific, Inc.
9.5 Agilent Technologies, Inc.
9.6 Perkin Elmer, Inc.
9.7 Illumina, Inc.
9.8 Shimadzu Corporation
9.9 Danaher Corporation
9.10 Abbott
LIST OF FIGURES:
Figure 4-1: Global - Microfluidics Market (Billion US$), 2017-2022
Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2017 & 2022
Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2017-2022
Figure 6-1: Global - Microfluidics Market by Material (%), 2017
Figure 6-2: Global – Microfluidics Market for Ceramics (Billion US$), 2017-2022
Figure 6-3: Global – Microfluidics Market for Polymers (Billion US$), 2017-2022
Figure 6-4: Global – Microfluidics Market for Others (Billion US$), 2017-2022
Figure 6-5: Global- Microfluidics Market by Components (%), 2017
Figure 6-6: Global – Microfluidics Chip Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-7: Global – Microfluidics Pumps Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-8: Global – Microfluidics Needles Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-9: Global – Other Microfluidic Components Market (Billion US$), 2017-2022
Figure 6-10: Global- Microfluidics Market by Applications (%), 2017
Figure 6-11: Global – Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2017-2022
Figure 6-12: Global – Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2017-2022
Figure 6-13: Global – Microfluidics Market for Drug Delivery (Billion US$), 2017-2022
Figure 6-14: Global – Microfluidics Market for Other Applications (Billion US$), 2017-2022
Figure 6-15: Global - Microfluidics Market by Geography (%), 2017
Figure 6-16: North America – Microfluidics Market (Billion US$), 2017-2022
Figure 6-17: Europe – Microfluidics Market (Billion US$), 2017-2022
Figure 6-18: Asia Pacific – Microfluidics Market (Billion US$), 2017-2022
Figure 6-19: RoW – Microfluidics Market (Billion US$), 2017-2022
Figure 9-1: Fluidigm Corporation - Revenue Breakup by Business Segment (%), 2017
Figure 9-2: Fluidigm Corporation - Revenue Breakup by Geography (%), 2017
Figure 9-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2017
Figure 9-4: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2017
Figure 9-5: Bio-Rad Laboratories, Inc. - Revenue Breakup by Business Segment (%), 2017
Figure 9-6: Bio-Rad Laboratories, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017
Figure 9-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-9: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017
Figure 9-10: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-11: Perkin Elmer, Inc. - Revenue Breakup by Business Segments (%), 2017
Figure 9-12: Perkin Elmer, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-13: Illumina, Inc. - Net Sales Break up by Business Segments (%), 2017
Figure 9-14: Illumina, Inc. - Net Sales Break up by Geography (%), 2017
Figure 9-15: Shimadzu Corporation - Net Sales Break up by Business Segments (%), 2017
Figure 9-16: Shimadzu Corporation - Net Sales Break up by Geography (%), 2017
Figure 9-17: Danaher Corporation - Revenue by Segment (%), 2017
Figure 9-18: Danaher Corporation - Revenue by Geography (%), 2017
Figure 9-19: Abbott - Revenue by Segment (%), 2017
Figure 9-20: Abbott - Revenue by Geography (%), 2017
List of Tables:
Table 5-1: Cost Involved in Microfluidics Chips
Table 6-1: Global - Cancer Incidences (Million), 2015 & 2025
Table 6-2: North America - Cancer Incidences (Million), 2015 & 2025
Table 6-3: Europe - Cancer Incidences (Million), 2015 & 2025
Table 6-4: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
Table 6-5: Rest of the World - Cancer Incidences (Million), 2015 & 2025
Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
Table 9-1: Fluidigm Corporation - Company Financials (Billion US$), 2015-2017
Table 9-2: F. Hoffmann-La Roche Ltd. - Company Financials (Billion US$), 2015-2017
Table 9-3: Bio-Rad Laboratories, Inc. - Company Financials (Billion US$), 2015-2017
Table 9-4: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2015-2017
Table 9-5: Agilent Technologies, Inc. - Key Financials (Million US$), 2015-2017
Table 9-6: Perkin Elmer, Inc. – Company Financials (Million US$), 2015-2017
Table 9-7: Illumina, Inc. - Net Sales (Million US$), 2015-2017
Table 9-8: Shimadzu Corporation - Net Sales (Million US$), 2015-2017
Table 9-9: Danaher Corporation - Net Sales (Million US$), 2015-2017
Table 9-10: Abbott - Net Sales (Million US$), 2015-2017
Figure 4-1: Global - Microfluidics Market (Billion US$), 2017-2022
Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2017 & 2022
Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2017-2022
Figure 6-1: Global - Microfluidics Market by Material (%), 2017
Figure 6-2: Global – Microfluidics Market for Ceramics (Billion US$), 2017-2022
Figure 6-3: Global – Microfluidics Market for Polymers (Billion US$), 2017-2022
Figure 6-4: Global – Microfluidics Market for Others (Billion US$), 2017-2022
Figure 6-5: Global- Microfluidics Market by Components (%), 2017
Figure 6-6: Global – Microfluidics Chip Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-7: Global – Microfluidics Pumps Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-8: Global – Microfluidics Needles Based Microfluidics Market (Billion US$), 2017-2022
Figure 6-9: Global – Other Microfluidic Components Market (Billion US$), 2017-2022
Figure 6-10: Global- Microfluidics Market by Applications (%), 2017
Figure 6-11: Global – Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2017-2022
Figure 6-12: Global – Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2017-2022
Figure 6-13: Global – Microfluidics Market for Drug Delivery (Billion US$), 2017-2022
Figure 6-14: Global – Microfluidics Market for Other Applications (Billion US$), 2017-2022
Figure 6-15: Global - Microfluidics Market by Geography (%), 2017
Figure 6-16: North America – Microfluidics Market (Billion US$), 2017-2022
Figure 6-17: Europe – Microfluidics Market (Billion US$), 2017-2022
Figure 6-18: Asia Pacific – Microfluidics Market (Billion US$), 2017-2022
Figure 6-19: RoW – Microfluidics Market (Billion US$), 2017-2022
Figure 9-1: Fluidigm Corporation - Revenue Breakup by Business Segment (%), 2017
Figure 9-2: Fluidigm Corporation - Revenue Breakup by Geography (%), 2017
Figure 9-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2017
Figure 9-4: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2017
Figure 9-5: Bio-Rad Laboratories, Inc. - Revenue Breakup by Business Segment (%), 2017
Figure 9-6: Bio-Rad Laboratories, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017
Figure 9-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-9: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017
Figure 9-10: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-11: Perkin Elmer, Inc. - Revenue Breakup by Business Segments (%), 2017
Figure 9-12: Perkin Elmer, Inc. - Revenue Breakup by Geography (%), 2017
Figure 9-13: Illumina, Inc. - Net Sales Break up by Business Segments (%), 2017
Figure 9-14: Illumina, Inc. - Net Sales Break up by Geography (%), 2017
Figure 9-15: Shimadzu Corporation - Net Sales Break up by Business Segments (%), 2017
Figure 9-16: Shimadzu Corporation - Net Sales Break up by Geography (%), 2017
Figure 9-17: Danaher Corporation - Revenue by Segment (%), 2017
Figure 9-18: Danaher Corporation - Revenue by Geography (%), 2017
Figure 9-19: Abbott - Revenue by Segment (%), 2017
Figure 9-20: Abbott - Revenue by Geography (%), 2017
List of Tables:
Table 5-1: Cost Involved in Microfluidics Chips
Table 6-1: Global - Cancer Incidences (Million), 2015 & 2025
Table 6-2: North America - Cancer Incidences (Million), 2015 & 2025
Table 6-3: Europe - Cancer Incidences (Million), 2015 & 2025
Table 6-4: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
Table 6-5: Rest of the World - Cancer Incidences (Million), 2015 & 2025
Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
Table 9-1: Fluidigm Corporation - Company Financials (Billion US$), 2015-2017
Table 9-2: F. Hoffmann-La Roche Ltd. - Company Financials (Billion US$), 2015-2017
Table 9-3: Bio-Rad Laboratories, Inc. - Company Financials (Billion US$), 2015-2017
Table 9-4: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2015-2017
Table 9-5: Agilent Technologies, Inc. - Key Financials (Million US$), 2015-2017
Table 9-6: Perkin Elmer, Inc. – Company Financials (Million US$), 2015-2017
Table 9-7: Illumina, Inc. - Net Sales (Million US$), 2015-2017
Table 9-8: Shimadzu Corporation - Net Sales (Million US$), 2015-2017
Table 9-9: Danaher Corporation - Net Sales (Million US$), 2015-2017
Table 9-10: Abbott - Net Sales (Million US$), 2015-2017
